Searched for
SUDEEP PHARMA SHARE PRICE
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Two Trades for Today: A realty major for a 6.6% rise, a mid-cap fertiliser maker’s stock for a 7% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Time for investors and traders to think alike? 7 Nifty Auto stocks with an upside potential of up to 19%There are sectors that have not quite followed the war script. Take the auto sector, for instance. A surge in oil prices is supposed to be ...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- These 7 private and public banking stocks have an upside of up to 26% in one year, according to analystsWhen it comes to banking, remember this: PSU and private banks have different kinds of loan books; at the end of the day, however, both ope...
- Pidilite Industries among 4 commodities stocks that hit 52-week highs and rallied up to 65% in a monthDeccan Gold Mines, Sudeep Pharma, Neogen Chemicals and Pidilite Industries touched fresh 52-week highs as the Sensex climbed 544 points. Th...
- DLF, Godrej Properties, and other realty stocks jump up to 13% in 3 days. Is the rally sustainable?Real estate stocks have surged nearly 9% in three days, with some analysts citing attractive valuations after a prolonged correction. This ...
- Crude Oil Price Today (June 15): Oil hits March lows, down 4% as US, Iran agree peace deal. What are experts saying?Brent Crude oil price : Brent crude futures fell $3.58, or 4.10%, to $83.75 a barrel, while U.S. West Texas Intermediate crude declined $4....
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Kospi jumps 6% as US-Iran peace deal triggers super surge; index up over 100% YTDSouth Korean stocks jumped 6% on Monday as easing geopolitical tensions lifted global risk sentiment after the US and Iran reached an initi...
- Nifty, Sensex to rally more on Monday? Iran peace deal among 5 factors to dictate Dalal Street this weekIndian benchmark indices rebounded sharply on Friday, with the Sensex and Nifty rising nearly 2%, driven by hopes of a US-Iran peace deal, ...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- MTAR Tech shares rally 12% after crashing 15% over 2 days. What lies ahead?MTAR Tech shares rebounded 12% after a sharp two-day fall triggered by concerns over a potential project pause linked to Bloom Energy. The ...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- TCS shares slip 2%, down 12% in 4 straight sessions. What’s triggering the decline?TCS shares tumbled 2% Monday, extending a four-day loss to 12%, as rising U.S. bond yields fueled fears of further Federal Reserve rate hik...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
Load More
